Gastrointestinal Radiology

, Volume 14, Issue 1, pp 55–58 | Cite as

Liver function tests in patients with computed tomography demonstrated hepatic metastases

  • Mark D. Ottmar
  • Roger L. GondaJr.
  • Kurt J. Leithauser
  • Oscar H. Gutierrez


One hundred patients with computed tomographic (CT) evidence of liver metastases (and confirmation by biopsy or progression of disease) had serum levels of alkaline phosphatase, serum glutamic oxaloacetic transaminase, and serum glutamic pyruvic transaminase measured within two weeks of scanning. All three enzymes were within the normal range in 33% of patients. Even with advanced involvement (defined as three or more metastatic lesions over 3 cm in diameter), 20% of patients had normal levels of all three liver enzymes. Although liver function tests (LFTs) (enzyme levels) are inexpensive and simple to perform, they failed to detect a significant number of patients with liver metastases.

Key words

Liver, computed tomography Liver, metastases 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lind SE, Singer DE: Diagnosing liver metastases: a Bayesian analysis.J Clin Oncol 4:379–388, 1986Google Scholar
  2. 2.
    Tartter PI, Slater G, Gelernt I, Aufses AH: Screening for liver metastases from colorectal cancer with carcinoembryonic antigen and alkaline phosphatase.Ann Surg 193:357–360, 1981Google Scholar
  3. 3.
    Bernardino ME, Thomas JL, Barnes PA, Lewis E: Diagnostic approaches to liver and spleen metastases.Radiol Clin North Am 20:469–485, 1982Google Scholar
  4. 4.
    Temple DF, Parthasarathy KL, Bakshi SP, Mittleman AE: A comparison of isotopic and computerized tomographic scanning in the diagnosis of metastases to the liver in patients with adenocarcinoma of the colon and rectum.Surg Gynaecol Obstet 156:205–208, 1983Google Scholar
  5. 5.
    Mendelsohn ML, Bodansky O: The value of liver function tests in the diagnosis of intrahepatic metastases in the nonicteric cancer patient.Cancer 5:1–8, 1952Google Scholar
  6. 6.
    Yesner R, Conn HO: Liver function tests and needle biopsy in the diagnosis of metastatic cancer to the liver.Ann Intern Med 59:62–73, 1963Google Scholar
  7. 7.
    Tempero MA, Petersen RJ, Zetterman RK, Lemon HM, Gurney J: Detection of metastatic liver disease — use of liver scans and biochemical liver tests.JAMA 248:1329–1332, 1982Google Scholar
  8. 8.
    Felix EL, Bagley DH, Sindelar WF et al.: The value of the liver scan in preoperative screening of patients with malignancies.Cancer 38:1137–1141, 1971Google Scholar
  9. 9.
    Nanji AA, Jetha N: Comparison of liver enzymes and liver scan in the detection of hepatic metastases.J Clin Hematol Oncol 12:17–23, 1982Google Scholar
  10. 10.
    Hanks JB, Jones RS: The pathogenesis, detection, and surgical treatment of hepatic metastases.Curr Probl Cancer 10:217–265, 1986Google Scholar
  11. 11.
    Lahr CJ, Soong SJ, Cloud G, Smith JW, Vrist MM, Balch CM: A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma.J Clin Oncol 1:720–726, 1983Google Scholar
  12. 12.
    Turonen MJ, Huituri K, Lempinen M: Results of 32 major hepatic resections for primary and secondary malignancies of the liver.Ann Chir Gynecol 75:209–214, 1986Google Scholar
  13. 13.
    Jones RS: Hepatic resection for metastatic cancer.Surg Ann 17:189–197, 1985Google Scholar
  14. 14.
    Hugnier M, Lacaine F: Hepatic metastases in gastrointestinal cancer — diagnostic value of biochemical investigations.Arch Surg 116:399–401, 1981Google Scholar
  15. 15.
    Gunven P, Makuuchi M, Takayasu K, Muriyama N, Yamasaki S, Hasegawa H: Preoperative imaging of liver metastases.Ann Surg 202:573–579, 1985Google Scholar
  16. 16.
    Ranson JHC, Adams PX, Localio SA: Preoperative assessment for hepatic metastases in carcinoma of the colon and rectum.Surg Gynaecol Obstet 137:436–438, 1973Google Scholar
  17. 17.
    Finlay IG, Meek DR, Gray HW, Duncan JG, McArdle CS: Incidence and detection of occult hepatic metastases in colorectal carcinoma.Br Med J 284:803–805, 1982Google Scholar
  18. 18.
    Cedermark BJ, Schultz SS, Bakshi S, Parthasarthy KL, Mittelman A, Evans JT: The value of liver scan in the follow-up study of patients with adenocarcinoma of the colon and rectum.Surg Gynaecol Obstet 144:745–748, 1977Google Scholar
  19. 19.
    Finlay IG, McArdle CS: Role of carcinoembryonic antigen in detection of asymptomatic disseminate disease in colorectal carcinoma.Br Med J 286:1242–1244, 1983Google Scholar
  20. 20.
    Kemeny MM, Ganteaume L, Goldberg DA, Hogan JM, Terz JJ: Preoperative staging with computerized axial tomography with biochemical laboratory tests in patients with hepatic metastases.Ann Surg 203:169–172, 1986Google Scholar
  21. 21.
    Kemeny MM, Sugarbaker PH, Smith TJ et al.: A prospective analysis of laboratory tests and imaging studies to detect hepatic lesions.Ann Surg 195:163–167, 1982Google Scholar
  22. 22.
    Canal P, Bugat R, Fernet P, Cassigneul J, Soula G: Biological appraisal of liver status in adenocarcinomas.Tumori 69:509–514, 1983Google Scholar
  23. 23.
    Helzberg JH, Spiro HM: ‘LFTs’ test more than liver — Editorial.JAMA 256:3006–3007, 1986Google Scholar
  24. 24.
    Gollin FF, Sims JL, Cameron JR: Liver scanning and liver function tests — a comparative study.JAMA 187:111–116, 1964Google Scholar
  25. 25.
    Jhingran SG, Jordan L, Johns MF, Haynie TP: Liver scintigrams compared with alkaline phosphatase and BSP determinations in the detection of metastatic carcinoma.J Nucl Med 12:227–230, 1971Google Scholar
  26. 26.
    Kilgore ES, Calabretta AM, Weidner WA, Graham WP: The accuracy of liver scanning in the detection of metastatic disease.J Surg Oncol 7:351–354, 1975Google Scholar
  27. 27.
    Maxfield WS, Ferrante WA, Shuler SE, Leslie CL: A comparison of diagnostic accuracy of liver scans, liver function tests, and liver biopsy.Prog Clin Cancer 5:55–70, 1973Google Scholar
  28. 28.
    Sugarbaker PH, Vermess M, Doppman JL, Miller DL, Simon R: Improved detection of focal lesions with computerized tomography examination of the liver using ethiodized oil emulsion (EOE-13) liver contrast.Cancer 54:1489–1495, 1984Google Scholar
  29. 29.
    Liwendahl K, Schauman KO: Statistical evaluation of liver scanning in combination with liver function tests.Act Med Scand 192:295–300, 1972Google Scholar
  30. 30.
    McGarrity TJ, Samuels T, Wilson FA: An analysis of imaging studies and liver function tests to detect hepatic neoplasia.Dig Dis Sci 32:1113–1117Google Scholar
  31. 31.
    Smith TJ, Kemeny MM, Sugarbaker PH et al.: A prospective study of hepatic imaging in the detection of metastatic disease.Ann Surg 194:486–491, 1982Google Scholar
  32. 32.
    Snow JH Jr, Goldstein HM, Wallace S: Comparison of scintigraphy and computed tomography in the evaluation of hepatic neoplasms.AJR 132:915–918, 1979Google Scholar
  33. 33.
    Larroquette CA, Hortobagyi GN, Buzdar AU, Holmes FA: Subclinical hepatic toxicity during combination chemotherapy for breast cancer.JAMA 256:2988–2989, 1986Google Scholar
  34. 34.
    Baden H, Andersen B, Augustenborg G, Hanel HK: Diagnostic value of gamma glutamyl transpeptidase and alkaline phosphatase in liver metastases.Surg Gynaecol Obstet 133:769–773, 1971Google Scholar
  35. 35.
    Mathews J, Slavin JD, Spencer RP: Liver function tests — a study in patients with imaging-demonstrated metastases.Clin Nucl Med 15:344–345, 1986Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1989

Authors and Affiliations

  • Mark D. Ottmar
    • 1
  • Roger L. GondaJr.
    • 2
  • Kurt J. Leithauser
    • 1
  • Oscar H. Gutierrez
    • 2
  1. 1.Department of Diagnostic Imaging and Interventional RadiologyProvidence HospitalSouthfieldUSA
  2. 2.Department of RadiologyUniversity of Rochester School of Medicine and DentistryRochesterUSA

Personalised recommendations